| Group P | Group PK1 | Group PK2 | Group PK3 | P value |
---|---|---|---|---|---|
Age (years) | 44.94 ± 10.031 | 42.71 ± 10.148 | 45.89 ± 9.292 | 44.38 ± 10.233 | 0.785 |
Gender (F) | 38 (58.5%) | 38 (58.5%) | 32 (49.2%) | 30 (46.2%) | 0.369 |
Weight (Kg) | 61.32 ± 10.053 | 60.77 ± 9.465 | 62.97 ± 9.352 | 60.52 ± 9.816 | 0.918 |
Height (cm) | 164.20 ± 7.688 | 163.28 ± 7.966 | 165.12 ± 7.962 | 165.65 ± 7.787 | 0.969 |
BMI | 22.67 ± 2.755 | 22.74 ± 2.664 | 23.06 ± 2.770 | 21.99 ± 2.730 | 0.961 |
ASA (I) | 43 (66.2%) | 39 (60.0%) | 42 (64.6%) | 42 (64.6%) | 0.896 |
Gastroscope | 65(100%) | 65(100%) | 65(100%) | 65(100%) | Â |
Colonoscopy | 65(100%) | 65(100%) | 65(100%) | 65(100%) | Â |
Comorbidities | |||||
Hypertension | 19 (29.2%) | 21 (32.3%) | 19 (29.2%) | 16 (24.6%) | 0.812 |
Diabetes | 6 (9.2%) | 2 (3.1%) | 6 (9.2%) | 3 (4.6%) | 0.377 |
Asthma | 0 (0%) | 0 (0%) | 1 (1.5%) | 0 (0%) | 1.000 |
COPD | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1.000 |
Tachycardia | 7 (10.8%) | 2 (3.1%) | 8 (12.3%) | 4 (6.2%) | 0.194 |
IHD | 0 (0%) | 1 (1.5%) | 0 (0%) | 0 (0%) | 1.000 |
Baseline | |||||
SpO2 (%) | 98.00 ± 0.919 | 97.82 ± 1.059 | 98.03 ± 1.000 | 98.05 ± 0.909 | 0.504 |
SBP (mm Hg) | 128.32 ± 17.057 | 126.75 ± 17.317 | 128.11 ± 17.540 | 124.85 ± 15.294 | 0.624 |
DBP (mm Hg) | 78.91 ± 10.728 | 78.57 ± 11.727 | 80.25 ± 9.548 | 75.46 ± 10.499 | 0.073 |
HR (bpm) | 85.46 ± 16.260 | 82.86 ± 14.992 | 84.43 ± 12.993 | 84.35 ± 14.303 | 0.793 |